Leyland, Nicholas http://orcid.org/0000-0003-3437-0723
Leonardi, Mathew
Murji, Ally
Singh, Sukhbir S.
Al-Hendy, Ayman
Bradley, Linda
Article History
Received: 13 December 2021
Accepted: 6 February 2022
First Online: 17 February 2022
Declarations
:
: Not applicable.
: Not applicable.
: Not applicable.
: N.L. has received funding/grant support from AbbVie and Bayer, and honorarium for consultancy from AbbVie, Baxter, Bayer, and TerSera. M.L. has received funding/grant support from AbbVie and the Australian Woman and Children’s Foundation, and honorarium for consultancy from Bayer, GE Healthcare, and TerSera. A.M. has received funding/grant support from AbbVie, and honorarium for consultancy from AbbVie, Bayer, and Pfizer. S.S. has received funding/grant support from AbbVie, Allergan, and Bayer, and honorarium for consultancy from AbbVie, Allergan, Bayer, Myovant, and TerSera. A.A-H. has received funding/grant support from the National Institute of Health and Crila, and honorarium for consultancy from AbbVie, Allergan, Bayer, Myovant, Novartis, and OBS-EVA. L.B. has received royalties from Elsevier, UpToDate, and Wolter Kluwers.